Tetraspanins in human epithelial malignancies

被引:77
作者
Romanska, Hanna M. [1 ]
Berditchevski, Fedor [2 ]
机构
[1] Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England
关键词
tetraspanins; human; epithelial; tumour; biomarker; METASTASIS-SUPPRESSOR GENE; SQUAMOUS-CELL CARCINOMA; HUMAN BREAST-CANCER; PROTEIN-1; MRP-1/CD9; EXPRESSION; HUMAN HEPATOCELLULAR-CARCINOMA; UROTHELIAL BLADDER-CARCINOMA; MESSENGER-RNA-EXPRESSION; LYMPH-NODE METASTASIS; DISEASE-FREE SURVIVAL; KAI1;
D O I
10.1002/path.2779
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transmembrane proteins of the tetraspanin superfamily are implicated in a broad spectrum of cellular processes in many biological systems in both health and disease. Tetraspanins form specialized membrane microdomains on the cell surface which control cell proliferation and migration through various adhesion and growth factor receptors. Recent extensive research has shown that expression of various tetraspanins and their associated partners is deregulated in human malignancies. Although, for the most part, the degree of involvement of tetraspanins in carcinogenesis remains to be established, increasing evidence suggests that these proteins might be of clinical significance in at least some malignancies. Here we provide a comprehensive review of the existing data on expression of tetraspanins in breast cancer and other human epithelial tumours, with an emphasis on their value as potential prognostic markers. Copyright (C) 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:4 / 14
页数:11
相关论文
共 95 条
[71]  
Sho M, 1998, INT J CANCER, V79, P509, DOI 10.1002/(SICI)1097-0215(19981023)79:5<509::AID-IJC11>3.0.CO
[72]  
2-X
[73]   Prognostic significance of CD9 expression in locally advanced gastric cancer treated with surgery and adjuvant chemoradiotherapy [J].
Soyuer, Serdar ;
Soyuer, Isin ;
Unal, Dilek ;
Ucar, Kadir ;
Yildiz, Oguz Galip ;
Orhan, Okan .
PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (09) :607-610
[74]   Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases [J].
Stark, AM ;
Tongers, K ;
Maass, N ;
Mehdorn, HM ;
Held-Feindt, J .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (03) :191-198
[75]   Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma [J].
Su, JS ;
Arima, K ;
Hasegawa, M ;
Franco, OE ;
Umeda, Y ;
Yanagawa, M ;
Sugimura, Y ;
Kawamura, J .
INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (02) :74-82
[76]  
Sun HC, 1998, J EXP CLIN CANC RES, V17, P307
[77]  
Tokuhara T, 2001, CLIN CANCER RES, V7, P4109
[78]   CD82 metastasis suppressor gene: a potential target for new therapeutics? [J].
Tonoli, H ;
Barrett, JC .
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (12) :563-570
[79]   KAI1 expression can be a predictor of stage A prostate cancer progression [J].
Tozawa, K ;
Akita, H ;
Kawai, N ;
Okamura, T ;
Sasaki, S ;
Hayashi, Y ;
Kohri, K .
PROSTATE CANCER AND PROSTATIC DISEASES, 2001, 4 (03) :150-153
[80]   The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation [J].
Tsai, Yien Che ;
Mendoza, Arnulfo ;
Mariano, Jennifer M. ;
Zhou, Ming ;
Kostova, Zlatka ;
Chen, Bo ;
Veenstra, Timothy ;
Hewitt, Stephen M. ;
Helman, Lee J. ;
Khanna, Chand ;
Weissman, Allan M. .
NATURE MEDICINE, 2007, 13 (12) :1504-1509